Furthermore, improved SOD activity has downstream effects, reducing the overall oxidative burden and minimizing inflammation, which is critical in OSA-associated cardiovascular and metabolic diseases. The gene discussed is SOD1; the disease is obstructive sleep apnea syndrome.